{"schema_version":"secwatch.filing_event.v1","accession":"0001653477-24-000080","form_type":"8-K","ticker":"NGVT","cik":"0001653477","company_name":"Ingevity Corp","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.979515+00:00","generated_at":"2026-05-31T14:24:46.356189+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Ingevity Q2 net loss $283.7M on goodwill impairment; guides FY sales $1.40-1.50B","bullets":["Net sales $390.6M, down 19% YoY; net loss of $283.7M ($7.81 diluted EPS) due to Performance Chemicals goodwill impairment.","Adjusted earnings $36.8M, adjusted diluted EPS $1.01; adjusted EBITDA $101.3M (25.9% margin).","Terminated a long-term crude tall oil supply contract; closing Crossett, AR facility for cost savings.","Revised FY 2024 guidance: sales $1.40-1.50B (from prior range) and adjusted EBITDA $350-360M.","Operating cash flow $29.7M; free cash flow $11.6M in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0001653477-24-000080","json":"https://secwatch.observer/filing/0001653477-24-000080.json","markdown":"https://secwatch.observer/filing/0001653477-24-000080.md","text":"https://secwatch.observer/filing/0001653477-24-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653477/000165347724000080/0001653477-24-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653477/000165347724000080/ngvt-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:24:46.356189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}